SpringWorks Therapeutics, Inc. (SWTX)

2 members of Congress have disclosed 3 trades in SpringWorks Therapeutics, Inc. (SWTX) via STOCK Act filings. The most recent disclosure was a sale by Josh Gottheimer on 2 July 2025. The most active traders have been Gilbert Cisneros (2) and Josh Gottheimer (1). Aggregate disclosed activity totals roughly $8K in purchases and $40.5K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for SWTX
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for SWTX

3 transactions
Compliance: 100%
Josh Gottheimer2 Jul 202511 Aug 2025SaleStock$1,001 - $15,000N/A
Gilbert Cisneros1 Jul 202510 Jul 2025SaleStock$15,001 - $50,000N/A
Gilbert Cisneros29 Jan 202511 Feb 2025PurchaseStock$1,001 - $15,000N/A

Stock Overview

Market Data

Market Cap

$3.54B

Volume

5.01M

Beta

0.70

P/E Ratio

-13.78

Fundamentals

EPS

$-3.41

Div. Yield

-

Open

$46.99

Day Range

$46.99 – $46.99

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Saqib Islam
IPO Date
2019-09-13
Website
www.springworkstx.com

SpringWorks Therapeutics, Inc. is a biopharmaceutical company dedicated to identifying, developing, and commercializing innovative therapies for patient populations grappling with rare diseases and various forms of cancer, often those with significan...

Earnings

Recent Quarters

Q2 20256 Aug
EPS$-0.54
Beat 33.3%
Q1 20259 May
EPS$-1.11
Miss 37.0%
Q4 202420 Feb
EPS$-1.04
Miss 44.4%
Q3 202412 Nov
EPS$-0.72
Beat 5.3%
Q2 20247 Aug
EPS$-0.54
Beat 51.8%
Q1 20242 May
EPS$-1.18
Miss 0.8%
Q4 202327 Feb
EPS$-1.44
Miss 15.2%
Q3 20232 Nov
EPS$-1.27
Beat 3.0%
Q2 20232 Aug
EPS$-1.25
Beat 0.0%
Q1 20233 May
EPS$-1.18
Beat 5.6%
Q4 202228 Feb
EPS$-1.19
Beat 1.6%
Q3 20223 Nov
EPS$-1.37
Miss 4.6%
Q2 20224 Aug
EPS$-1.41
Miss 11.9%
Q1 20225 May
EPS$-1.26
Miss 17.8%
Q4 202124 Feb
EPS$-1.15
Miss 32.2%
Q3 20214 Nov
EPS$-0.84
Miss 9.1%
Q2 20214 Aug
EPS$-0.97
Miss 38.6%
Q1 20216 May
EPS$-0.62
Miss 21.6%
Q4 202025 Feb
EPS$0.30
Beat 400.0%
Q3 202012 Nov
EPS$-0.51
Miss 4.1%
Q2 202012 Aug
EPS$-0.47
Miss 51.6%
Q1 202012 May
EPS$-0.37
Beat 7.5%
Q4 201912 Mar
EPS$-0.39
Miss 5.4%
Q3 201912 Nov
EPS$-1.77
Miss 277.5%
Q2 201913 Sept
EPS$-0.51
Q1 201930 Jun
EPS$-0.33
Q3 201831 Dec
EPS$-0.28
Q2 201830 Sept
EPS$-0.23
Q1 201830 Jun
EPS$-18.80
Q4 201731 Mar
EPS$-18.80

1 politician traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about SWTX

Which members of Congress have traded SWTX?
2 members of Congress have disclosed 3 trades in SpringWorks Therapeutics, Inc. (SWTX) under the STOCK Act. The most active traders are Gilbert Cisneros and Josh Gottheimer.
When was SWTX most recently disclosed by Congress?
The most recent SWTX disclosure was a sale by Josh Gottheimer on 2 July 2025.
What is the total disclosed congressional trading volume for SWTX?
Members of Congress have disclosed approximately $8K in SWTX purchases and $40.5K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in SWTX?
This SWTX page updates as soon as new STOCK Act disclosures are filed for SpringWorks Therapeutics, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.